Bempedoic Acid
Bempedoic Acid (Nilemdo) is a cholesterol-lowering medication that works differently from statins. It targets an earlier step in the cholesterol production pathway in your liver, making it an option for people who need additional LDL reduction or cannot tolerate statins.
Key points
- Unlike statins, its action is confined to the liver rather than muscle, which may explain its lower rate of muscle-related reactions.
- It can be added to a statin when cholesterol targets are not reached, or used alone by patients who cannot tolerate statins.
- Nilemdo and Nexletol are brand names for the same active compound, approved separately under different licences.
What is Bempedoic Acid?
Bempedoic Acid is a pharmaceutical medication classified as an ATP citrate lyase inhibitor. It belongs to a newer class of cholesterol-lowering drugs that complement statins rather than replace them entirely. The active compound is taken as a film-coated tablet once daily.
Several brand names exist because the medication has been developed and licensed across different regions. The originator brand Nilemdo is approved in various markets, while Nexletol is the brand name used in the United States. Both contain the same active compound.
What Bempedoic Acid is used for
Bempedoic Acid is used for adults with Primary Hypercholesterolaemia or Mixed Dyslipidaemia who need to lower their LDL cholesterol further. It is typically added to a statin or other lipid-lowering therapy when target cholesterol levels have not been reached. It may also be used alone for patients who cannot take statins.
How does Bempedoic Acid work?
Bempedoic Acid blocks an enzyme called ATP citrate lyase, which your liver uses early in the process of making cholesterol. By inhibiting this step, less cholesterol is produced, and your liver pulls more LDL out of your bloodstream. Unlike statins, it is activated only in the liver and not in muscle tissue, which may explain why it tends to cause fewer muscle-related reactions.
Bempedoic Acid brands and forms
The medication is available as a film-coated tablet, designed for once-daily oral use. The listed brands include Nilemdo and Nexletol, which are bioequivalent formulations of the same active compound. Choosing between brands often comes down to availability and regional approval rather than differences in how the medicine works. For patients managing cardiovascular risk, this medication sits within the broader category of Cholesterol Management and Heart & Blood Pressure treatments.
Safety overview for Bempedoic Acid
What to check before using this medicine
Inform your doctor about any history of gout, liver conditions, or tendon problems before starting this medication. Kidney function and existing lipid-lowering treatments should also be reviewed.
Possible reactions and tolerability
Some people experience increases in uric acid levels, which may trigger gout. Muscle cramps, back pain, and changes in liver enzymes have been reported. Most reactions are mild, but any unusual symptoms should be discussed with a healthcare professional.
Interactions and health factors
Bempedoic Acid may interact with statins and other lipid-lowering medications. Combining treatments requires medical supervision to monitor cholesterol response and tolerability. Your doctor will assess whether this medication fits your overall treatment plan.
Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.